Bosh sahifaADVM • NASDAQ
add
Adverum Biotechnologies Inc
3,02 $
Seans yopilganidan keyin:(1,99%)+0,060
3,08 $
Yopilgan:12-sen, 20:00:00 (GMT-4) · USD · NASDAQ · Ogohlantirish
Yopilish kursi
3,14 $
Kunlik diapazon
2,95 $ - 3,08 $
Yillik diapazon
1,78 $ - 8,56 $
Bozor kapitalizatsiyasi
63,37 mln USD
Oʻrtacha hajm
91,34 ming
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | — | — |
Joriy xarajat | 12,73 mln | -19,47% |
Sof foyda | -49,19 mln | -61,29% |
Sof foyda marjasi | — | — |
Har bir ulushga tushum | -2,34 | -162,92% |
EBITDA | -49,32 mln | -54,38% |
Amaldagi soliq stavkasi | — | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 44,40 mln | -74,46% |
Jami aktivlari | 96,18 mln | -62,10% |
Jami passivlari | 116,40 mln | 35,70% |
Umumiy kapital | -20,22 mln | — |
Tarqatilgan aksiyalar | 20,98 mln | — |
Narxi/balansdagi bahosi | -3,27 | — |
Aktivlardan daromad | -106,60% | — |
Kapitaldan daromad | -130,10% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -49,19 mln | -61,29% |
Operatsiyalardan naqd pul | -38,77 mln | -95,36% |
Sarmoyadan naqd pul | 31,90 mln | 1 471,04% |
Moliyadan naqd pul | 120,00 ming | 203,45% |
Naqd pulning sof oʻzgarishi | -6,74 mln | 69,74% |
Boʻsh pul | -19,80 mln | -35,25% |
Haqida
Adverum Biotechnologies, Inc., formerly known as Avalanche Biotechnologies, is a publicly traded clinical stage gene therapy company located in Redwood City, California. The company is targeting unmet medical needs for serious ocular and rare diseases, including wet age-related macular degeneration. Wikipedia
Tashkil etilgan
1-yan, 2006
Sayt
Xodimlar soni
155
